COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

11.39 -0.51 (-4.29%)

Delayed Quote Updated: 11:06 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

33 34 Next >

10 Short Squeeze Candidates: Getty Images Tops List, PaxMedica Rejoins Top Five, MicroStrategy Moves Up And More ↗

April 10, 2023

Potential short squeeze plays gained steam in 2021 and continued through 2023 with new traders looking for the next huge move. High short interest and high cost to borrow are among the common traits...

Via Benzinga

Psychedelic Stock Gainers And Losers From April 7, 2023 ↗

April 07, 2023

Via Benzinga

Psychedelic Stock Gainers And Losers From April 6, 2023 ↗

April 06, 2023

Via Benzinga

Compass Pathways, GH Research Among Top Psychedelic Movers Of Today ↗

April 05, 2023

Via Benzinga

Psychedelic Stock Gainers And Losers From April 4, 2023 ↗

April 04, 2023

Via Benzinga

Compass Pathways Plc (NASDAQ: CMPS) Highlighted for Surprising Price Action

April 04, 2023

Via Investor Brand Network

Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗

April 03, 2023

Via Benzinga

What To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging Industry ↗

April 03, 2023

The world of psychedelics is evolving rapidly, and the Benzinga Psychedelics Capital Conference is the premier event for those who want to be part of this exciting journey.

Via Benzinga

5 Short Squeeze Stocks To Watch: Unicycle Therapeutics, Getty Images And More ↗

April 03, 2023

Potential short squeeze plays gained steam in 2021 and continued through 2022 with new traders looking for the next huge move. High short interest and high cost to borrow are among the common traits...

Via Benzinga

Largest Psychedelic Stocks -3.4% In March ↗

April 02, 2023

The munKNEE Psychedelic Drug Stocks Index was down 3.4% in March but is still +1.2% YTD. The best news is the continuing high price targets being set by analysts.

Via Talk Markets

Psychedelic Stock Gainers And Losers From March 31, 2023 ↗

March 31, 2023

Via Benzinga

Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today ↗

March 30, 2023

Via Benzinga

Psychedelic Stock Gainers And Losers From March 29, 2023 ↗

March 29, 2023

Via Benzinga

Psychedelic Stock Gainers And Losers From March 28, 2023 ↗

March 28, 2023

Via Benzinga

Psychedelic Stock Gainers And Losers From March 27, 2023 ↗

March 27, 2023

Via Benzinga

10 Short Squeeze Candidates: Unicycle Therapeutics, Compass Pathways, Virgin Orbit Among Those To Watch ↗

March 27, 2023

Potential short squeeze plays gained steam in 2021 and continued through 2022 with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits...

Via Benzinga

Cannabis Category Performances Ranged From +8.6% To -7.0% This Week ↗

March 25, 2023

The 5 categories in the cannabis sector perform quite differently from each other and this week was a prime example.

Via Talk Markets

GH Research, Cybin Among Top Psychedelic Movers Of Today ↗

March 24, 2023

Via Benzinga

Atai Life Sciences Hopes Hercules Can Help 'Sustain' Operations Until 2026 ↗

March 24, 2023

Biopharma company Atai Life Sciences' (NASDAQ: ATAI) fourth quarter and full year 2022 consolidated financial results show:

Via Benzinga

GH Research, Compass Pathways Among Top Psychedelic Movers Of Today ↗

March 23, 2023

Via Benzinga

Psychedelic Stock Gainers And Losers From March 22, 2023 ↗

March 22, 2023

Via Benzinga

Psychedelic Stock Gainers And Losers From March 21, 2023 ↗

March 21, 2023

Via Benzinga

EXCLUSIVE: NYC Ketamine Center Co-Founder On Prices, Insurance, Competition & Expansion ↗

March 21, 2023

This is the third article of a three-part series, you can find the first and

Via Benzinga

Psychedelic Stock Gainers And Losers From March 20, 2023 ↗

March 20, 2023

Via Benzinga

Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More ↗

March 20, 2023

Psychedelics Reform Update: 22 States Where Proposals Are Being Discussed & Local Moves Considered

Via Benzinga

The "Rags-To-Riches" Portfolio: An Update ↗

March 18, 2023

Cannabis, psychedelic, and plant-based food stocks performed extremely poorly in 2022, down 73% vs. 2021 but perhaps some of them will bounce back with major returns in 2023.

Via Talk Markets

Psychedelic Stock Gainers And Losers From March 17, 2023 ↗

March 17, 2023

Via Benzinga

Seelos Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today ↗

March 16, 2023

Via Benzinga

Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today ↗

March 15, 2023

Via Benzinga

COMPASS Pathways: New Data & Insight On Psilocybin Therapy For Treatment-Resistant Depression ↗

March 14, 2023

COMPASS Pathways' (NASDAQ: CMPS) Phase 2b study of synthetic psilocybin COMP360 paired with psychological support for Treatment-Resistant Depression (TR

Via Benzinga

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

33 34 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.